APA (7th ed.) Citation

Wallentin, L., James, S., Storey, R. F., Armstrong, M., Barratt, B. J., Horrow, J., . . . Becker, R. C. (2010). Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: A genetic substudy of the PLATO trial. The lancet, 376(9749), . https://doi.org/10.1016/S0140-6736(10)61274-3

Chicago Style (17th ed.) Citation

Wallentin, Lars, et al. "Effect of CYP2C19 and ABCB1 Single Nucleotide Polymorphisms on Outcomes of Treatment with Ticagrelor Versus Clopidogrel for Acute Coronary Syndromes: A Genetic Substudy of the PLATO Trial." The Lancet 376, no. 9749 (2010). https://doi.org/10.1016/S0140-6736(10)61274-3.

MLA (9th ed.) Citation

Wallentin, Lars, et al. "Effect of CYP2C19 and ABCB1 Single Nucleotide Polymorphisms on Outcomes of Treatment with Ticagrelor Versus Clopidogrel for Acute Coronary Syndromes: A Genetic Substudy of the PLATO Trial." The Lancet, vol. 376, no. 9749, 2010, https://doi.org/10.1016/S0140-6736(10)61274-3.